Michael Johnson
Family · Foxworth, MSNPI 1033223995
Payments from drug & device makers
Across 101 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$438
- Novo Nordisk$413
- Pfizer$301
- AbbVie$186
- Lilly USA, LLC$129
- AstraZeneca$78
- plus $277 from 9 others
What the payments were for
- Food & beverage$1,823100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $438 |
| Novo Nordisk | 25 | $413 |
| Pfizer | 16 | $301 |
| AbbVie | 11 | $186 |
| Lilly USA, LLC | 8 | $129 |
| AstraZeneca | 4 | $78 |
| Boehringer Ingelheim | 4 | $74 |
| Abbott | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Bayer | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| IBSA Pharma Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$1,823 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $113,844 |
| LinzessLinaclotide | 66 | $47,874 |
| MounjaroTirzepatide | 38 | $44,911 |
| JardianceEmpagliflozin | 49 | $43,774 |
| JanuviaSitagliptin Phosphate | 49 | $35,605 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $20,648 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $20,164 |
| EliquisApixaban | 19 | $12,293 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $11,110 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $10,391 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $6,576 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,244 |
| Ventolin HfaAlbuterol Sulfate | 38 | $2,700 |
| Gabapentin | 274 | $2,632 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 172 | $2,593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $413 | $113,84473 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $74 | $54,16564 claims |
| AbbVieLinzess, Synthroid | $186 | $49,68893 claims |
| Lilly USA, LLCMounjaro | $129 | $44,91138 claims |
| MerckJanuvia | $19 | $35,60549 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $78 | $26,74044 claims |
| PfizerEliquis | $301 | $12,29319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,007 family providers in Mississippi.
Other family in Foxworth
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.